@article{article, title  = {{Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12}},

 publisher = {{The Endocrine Society}},

 url = {{http://dx.doi.org/10.1210/clinem/dgae611 }},

 year = {{2024}},

 month = {{9}},

 author = {{Langdahl B and Chung Y-S and Plebanski R and Czerwinski E and Dokoupilova E and Supronik J and Rosa J and Mydlak A and Rowińska-Osuch A and Baek K-H and Urboniene A et al}},

 doi = {{10.1210/clinem/dgae611}},

 journal = {{The Journal of Clinical Endocrinology & Metabolism}},

 note = {{Accessed on 2024/12/23}}}